The risk of smoking on multiple sclerosis: A meta-analysis based on 20,626 cases from case-control and cohort studies

PeerJ

Volumn 2016, Issue 3, 2016, Pages

  Zhang, Peng ^a   Wang, Rui ^a   Li, Zhijun ^a   Wang, Yuhan ^a   Gao, Chunshi ^a   Lv, Xin ^a   Song, Yuanyuan ^a   Li, Bo ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Meta analysis; Multiple sclerosis; Smoking

Indexed keywords

ARTICLE; DATA EXTRACTION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENDER; HUMAN; MALE; META ANALYSIS; MULTIPLE SCLEROSIS; PASSIVE SMOKING; RISK FACTOR; SMOKING;

EID: 84963956639     PISSN: None     EISSN: 21678359     Source Type: Journal    
DOI: 10.7717/peerj.1797     Document Type: Article

References (73)

1. Al-Afasy HH, Al-Obaidan MA, Al-Ansari YA, Al-Yatama SA, Al-Rukaibi MS, Makki NI, Suresh A, Akhtar S. 2013. Risk factors for multiple sclerosis in Kuwait: a populationbased case-control study. Neuroepidemiology 40:30-35 DOI 10.1159/000341240.
2. Alonso A, Cook SD, Maghzi AH, Divani AA. 2011. A case-control study of risk factors for multiple sclerosis in Iran. Multiple Sclerosis Journal 17:550-555 DOI 10.1177/1352458510397685.
3. Asadollahi S, Fakhri M, Heidari K, Zandieh A, Vafaee R, Mansouri B. 2013. Cigarette smoking and associated risk of multiple sclerosis in the Iranian population. Journal of Clinical Neuroscience 20:1747-1750 DOI 10.1016/j.jocn.2013.01.018.
4. Ascherio A, Munger KL. 2007. Environmental risk factors for multiple sclerosis. Part II: noninfectious factors. Annals of Neurology 61:504-513 DOI 10.1002/ana.21141.
5. Ascherio A, Munger KL, Simon KC. 2010. Vitamin D and multiple sclerosis. The Lancet Neurology 9:599-612 DOI 10.1016/S1474-4422(10)70086-7.
6. Baarnhielm M, Hedstrom AK, Kockum I, Sundqvist E, Gustafsson SA, Hillert J, Olsson T, Alfredsson L. 2012. Sunlight is associated with decreased multiple sclerosis risk: no interaction with human leukocyte antigen-DRB1*15. European Journal of Neurology 19:955-962 DOI 10.1111/j.1468-1331.2011.03650.x.
7. Begg CB, Mazumdar M. 1994. Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101 DOI 10.2307/2533446.
8. Bland JM, Altman DG. 2000. Statistics notes. The odds ratio. BMJ 320:1468 DOI 10.1136/bmj.320.7247.1468.
9. Briggs FB, Acuna B, Shen L, Ramsay P, Quach H, Bernstein A, Bellesis KH, Kockum IS, Hedstrom AK, Alfredsson L, Olsson T, Schaefer C, Barcellos LF. 2014. Smoking and risk of multiple sclerosis: evidence of modification by NAT1 variants. Epidemiol-ogy 25:605-614 DOI 10.1097/EDE.0000000000000089.
10. Brosseau L, Philippe P, Methot G, Duquette P, Haraoui B. 1993. Drug abuse as a risk factor of multiple sclerosis: case-control analysis and a study of heterogeneity. Neuroepidemiology 12:6-14 DOI 10.1159/000110294.
11. Carlens C, Hergens MP, Grunewald J, Ekbom A, Eklund A, Hoglund CO, Askling J. 2010. Smoking, use of moist snuff, and risk of chronic inflammatory diseases. American Journal of Respiratory and Critical Care Medicine 181:1217-1222 DOI 10.1164/rccm.200909-1338OC.
12. Clayton D, Hills M. 1993. Statistical models in epidemiology. Oxford: Oxford University Press.
13. Collaborators, GMaCoD. 2015. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385:117-171 DOI 10.1016/S0140-6736(14)61682-2.
14. Compston A, Coles A. 2002. Multiple sclerosis. Lancet 359:1221-1231 DOI 10.1016/S0140-6736(02)08220-X.
15. Compston A, Coles A. 2008. Multiple sclerosis. Lancet 372:1502-1517 DOI 10.1016/S0140-6736(08)61620-7.
16. Dobosz C, Tyrpien K, Pierzchala K. 2012. Assessment of exposure to tobacco smoke in a selected group of patients with multiple sclerosis from the Upper Silesia region. Przeglad Lekarski 69:940-943.
17. Egger M, Davey Smith G, Schneider M, Minder C. 1997. Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634 DOI 10.1136/bmj.315.7109.629.
18. Frutos-Alegria MT, Beltran-Blasco I, Quilez-Iborra C, Molto-Jorda J, Diaz-Marin C, Matias-Guiu J. 2002a. A control and case study of multiple sclerosis in the Alicante and Villajoyosa areas. Revue Neurologique 34:1013-1016.
19. Frutos Alegria MT, Beltran-Blasco I, Quilez-Iborra C, Molto-Jorda J, Diaz-Marin C, Matias-Guiu J. 2002b. The epidemiology of multiples sclerosis in Alcoi. Analytical data. Revue Neurologique 34:813-816.
20. Ghadirian P, Dadgostar B, Azani R, Maisonneuve P. 2001. A case-control study of the association between socio-demographic, lifestyle and medical history factors and multiple sclerosis. Canadian Journal of Public Health. Revue Canadienne de Sante Publique 92:281-285.
21. Grimaldi LM, Salemi G, Grimaldi G, Rizzo A, Marziolo R, Lo Presti C, Maimone D, Savettieri G. 2001. High incidence and increasing prevalence of MS in Enna (Sicily), southern Italy. Neurology 57:1891-1893 DOI 10.1212/WNL.57.10.1891.
22. Guimond C, Lee JD, Ramagopalan SV, Dyment DA, Hanwell H, Giovannoni G, Criscuoli M, Yee IM, Vorobeychik G, Ebers GC, Sadovnick AD. 2014. Multiple sclerosis in the Iranian immigrant population of BC, Canada: prevalence and risk factors. Multiple Sclerosis 20(9):1182-1188. Available at http://msj.sagepub.com/content/20/9/1182.long.
23. Gustavsen MW, Page CM, Moen SM, Bjolgerud A, Berg-Hansen P, Nygaard GO, Sandvik L, Lie BA, Celius EG, Harbo HF. 2014. Environmental exposures and the risk of multiple sclerosis investigated in a Norwegian case-control study. BMC Neurology 14:196 DOI 10.1186/s12883-014-0196-x.
24. Handel AE, Handunnetthi L, Giovannoni G, Ebers GC, Ramagopalan SV. 2010. Genetic and environmental factors and the distribution of multiple sclerosis in Europe. Euro-pean Journal of Neurology 17:1210-1214 DOI 10.1111/j.1468-1331.2010.03003.x.
25. Handel AE, Williamson AJ, Disanto G, Dobson R, Giovannoni G, Ramagopalan SV. 2011. Smoking and multiple sclerosis: an updated meta-analysis. PLoS ONE 6:e16149 DOI 10.1371/journal.pone.0016149.
26. Hawkes CH. 2007. Smoking is a risk factor for multiple sclerosis: a metanalysis. Multiple Sclerosis 13:610-615 DOI 10.1177/1352458506073501.
27. Hedstrom AK, Akerstedt T, Hillert J, Olsson T, Alfredsson L. 2011a. Shift work at young age is associated with increased risk for multiple sclerosis. Annals of Neurology 70:733-741 DOI 10.1002/ana.22597.
28. Hedstrom AK, Baarnhielm M, Olsson T, Alfredsson L. 2009. Tobacco smoking, but not Swedish snuffuse, increases the risk of multiple sclerosis. Neurology 73:696-701 DOI 10.1212/WNL.0b013e3181b59c40.
29. Hedstrom AK, Bomfim IL, Barcellos LF, Briggs F, Schaefer C, Kockum I, Olsson T, Alfredsson L. 2014a. Interaction between passive smoking and two HLA genes with regard to multiple sclerosis risk. International Journal of Epidemiology 43:1791-1798 DOI 10.1093/ije/dyu195.
30. Hedstrom AK, Hillert J, Olsson T, Alfredsson L. 2013a. Nicotine might have a protective effect in the etiology of multiple sclerosis. Multiple Sclerosis 19:1009-1013 DOI 10.1177/1352458512471879.
31. Hedstrom AK, Hillert J, Olsson T, Alfredsson L. 2013b. Smoking and multiple sclerosis susceptibility. European Journal of Epidemiology 28:867-874 DOI 10.1007/s10654-013-9853-4.
32. Hedstrom AK, Hillert J, Olsson T, Alfredsson L. 2014b. Alcohol as a modifiable lifestyle factor affecting multiple sclerosis risk. JAMA Neurology 71:300-305 DOI 10.1001/jamaneurol.2013.5858.
33. Hedstrom AK, Sundqvist E, Baarnhielm M, Nordin N, Hillert J, Kockum I, Olsson T, Alfredsson L. 2011b. Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis. Brain 134:653-664 DOI 10.1093/brain/awq371.
34. Hernan MA, Jick SS, Logroscino G, Olek MJ, Ascherio A, Jick H. 2005. Cigarette smoking and the progression of multiple sclerosis. Brain 128:1461-1465 DOI 10.1093/brain/awh471.
35. Hernan MA, Olek MJ, Ascherio A. 2001. Cigarette smoking and incidence of multiple sclerosis. American Journal of Epidemiology 154:69-74 DOI 10.1093/aje/154.1.69.
36. Jafari N, Hintzen RQ. 2011. The association between cigarette smoking and multiple sclerosis. Journal of the Neurological Sciences 311:78-85 DOI 10.1016/j.jns.2011.09.008.
37. Jafari N, Hoppenbrouwers IA, Hop WC, Breteler MM, Hintzen RQ. 2009. Cigarette smoking and risk of MS in multiplex families. Multiple Sclerosis 15:1363-1367 DOI 10.1177/1352458509345907.
38. Kotzamani D, Panou T, Mastorodemos V, Tzagournissakis M, Nikolakaki H, Spanaki C, Plaitakis A. 2012. Rising incidence of multiple sclerosis in females associated with urbanization. Neurology 78:1728-1735 DOI 10.1212/WNL.0b013e31825830a9.
39. Lauer K. 2006. Divergent risk of multiple sclerosis in two anabaptist communities in America. Medical Hypotheses 67:969-974 DOI 10.1016/j.mehy.2006.03.044.
40. Maghzi AH, Etemadifar M, Heshmat-Ghahdarijani K, Moradi V, Nonahal S, Ghor-bani A, Minagar A. 2011. Cigarette smoking and the risk of multiple sclerosis: a sibling case-control study in Isfahan, Iran. Neuroepidemiology 37:238-242 DOI 10.1159/000332765.
41. Makrygiannakis D, Hermansson M, Ulfgren AK, Nicholas AP, Zendman AJ, Eklund A, Grunewald J, Skold CM, Klareskog L, Catrina AI. 2008. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Annals of the Rheumatic Diseases 67:1488-1492 DOI 10.1136/ard.2007.075192.
42. Mansouri B, Asadollahi S, Heidari K, Fakhri M, Assarzadegan F, Nazari M, Divani A. 2014. Risk factors for increased multiple sclerosis susceptibility in the Iranian population. Journal of Clinical Neuroscience 21:2207-2211 DOI 10.1016/j.jocn.2014.04.020.
43. Milo R, Kahana E. 2010. Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmunity Reviews 9:A387-A394 DOI 10.1016/j.autrev.2009.11.010.
44. Mortaz E, Lazar Z, Koenderman L, Kraneveld AD, Nijkamp FP, Folkerts G. 2009. Cigarette smoke attenuates the production of cytokines by human plasmacytoid dendritic cells and enhances the release of IL-8 in response to TLR-9 stimulation. Respiratory Research 10:1-9 DOI 10.1186/1465-9921-10-47.
45. Munger KL, Chitnis T, Ascherio A. 2009. Body size and risk of MS in two cohorts of US women. Neurology 73:1543-1550 DOI 10.1212/WNL.0b013e3181c0d6e0.
46. Munger KL, Peeling RW, Hernan MA, Chasan-Taber L, Olek MJ, Hankinson SE, Hunter D, Ascherio A. 2003. Infection with Chlamydia pneumoniae and risk of multiple sclerosis. Epidemiology 14:141-147.
47. Nortvedt MW, Riise T, Maeland JG. 2005. Multiple sclerosis and lifestyle factors: the Hordaland Health Study. Neurological Science 26:334-339 DOI 10.1007/s10072-005-0498-2.
48. O'Gorman C, Broadley SA. 2014. Smoking and multiple sclerosis: evidence for latitudinal and temporal variation. Journal of Neurology 261:1677-1683 DOI 10.1007/s00415-014-7397-5.
49. O'Gorman C, Bukhari W, Todd A, Freeman S, Broadley SA. 2014. Smoking increases the risk of multiple sclerosis in Queensland, Australia. Journal of Clinical Neuro-science 21:1730-1733 DOI 10.1016/j.jocn.2014.01.009.
50. Pace E, Ferraro M, Siena L, Melis M, Montalbano AM, Johnson M, Bonsignore MR, Bonsignore G, Gjomarkaj M. 2008. Cigarette smoke increases Toll-like receptor 4 and modifies lipopolysaccharide-mediated responses in airway epithelial cells. Immunology 124:401-411 DOI 10.1111/j.1365-2567.2007.02788.x.
51. Pekmezovic T, Drulovic J, Milenkovic M, Jarebinski M, Stojsavljevic N, Mesaros S, Kisic D, Kostic J. 2006. Lifestyle factors and multiple sclerosis: a case-control study in Belgrade. Neuroepidemiology 27:212-216 DOI 10.1159/000096853.
52. Pugliatti M, Sotgiu S, Rosati G. 2002. The worldwide prevalence of multiple sclerosis. Clinical Neurology and Neurosurgery 104:182-191 DOI 10.1016/S0303-8467(02)00036-7.
53. Ragnedda G, Leoni S, Parpinel M, Casetta I, Riise T, Myhr KM, Wolfson C, Pugliatti M. 2015. Reduced duration of breastfeeding is associated with a higher risk of multiple sclerosis in both Italian and Norwegian adult males: the EnvIMS study. Journal of Neurology 262:1271-1277 DOI 10.1007/s00415-015-7704-9.
54. Ragonese P, Castiglia G, Cusimano V, Battaglieri F, Salemi G. 2007. Cigarette smoking, coffee consumption and multiple sclerosis risk: a case-control study. Acta Medica Mediterranea 23:133-140.
55. Ramagopalan SV, Lee JD, Yee IM, Guimond C, Traboulsee AL, Ebers GC, Sadovnick AD. 2013. Association of smoking with risk of multiple sclerosis: a population-based study. Journal of Neurology 260:1778-1781 DOI 10.1007/s00415-013-6873-7.
56. Ramagopalan SV, Maugeri NJ, Handunnetthi L, Lincoln MR, Orton SM, Dyment DA, Deluca GC, Herrera BM, Chao MJ, Sadovnick AD, Ebers GC, Knight JC. 2009. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genetics 5:e1000369 DOI 10.1371/journal.pgen.1000369.
57. Riise T, Nortvedt MW, Ascherio A. 2003. Smoking is a risk factor for multiple sclerosis. Neurology 61:1122-1124 DOI 10.1212/01.WNL.0000081305.66687.D2.
58. Rodriguez Regal A, Del Campo Amigo M, Paz-Esquete J, Martinez Feijoo A, Cebrian E, Suarez Gil P, Mourino MA. 2009. A case-control study of the influence of the smoking behaviour in multiple sclerosis. Neurologia 24:177-180.
59. Russo C, Morabito F, Luise F, Piromalli A, Battaglia L, Vinci A, Trapani Lombardo V, De Marco V, Morabito P, Condino F, Quattrone A, Aguglia U. 2008. Hyperhomocysteinemia is associated with cognitive impairment in multiple sclerosis. Journal of Neurology 255:64-69 DOI 10.1007/s00415-007-0668-7.
60. Scolding N, Franklin R. 1998. Axon loss in multiple sclerosis. Lancet 352:340-341 DOI 10.1016/S0140-6736(05)60463-1.
61. Senecal-Quevillon M, Duquette P, Richer CL. 1986. Analysis of sister-chromatid exchanges (SCEs) in familial and sporadic multiple sclerosis. Mutation Research/DNA Repair 161:65-74.
62. Silva KR, Alvarenga RM, Fernandez YFO, Alvarenga H, Thuler LC. 2009. Potential risk factors for multiple sclerosis in Rio de Janeiro: a case-control study. Arquivos de Neuro-Psiuiatria 67:229-234.
63. Simon KC, O'Reilly EJ, Munger KL, Finerty S, Morgan AJ, Ascherio A. 2012. Epstein-Barr virus neutralizing antibody levels and risk of multiple sclerosis. Multiple Sclerosis 18:1185-1187 DOI 10.1177/1352458511433920.
64. Simon KC, Schmidt H, Loud S, Ascherio A. 2015. Risk factors for multiple sclerosis, neuromyelitis optica and transverse myelitis. Multiple Sclerosis 21:703-709 DOI 10.1177/1352458514551780.
65. Simon KC, Van der Mei IA, Munger KL, Ponsonby A, Dickinson J, Dwyer T, Sund-strom P, Ascherio A. 2010. Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk. Neurology 74:1365-1371 DOI 10.1212/WNL.0b013e3181dad57e.
66. Smith KJ, Kapoor R, Felts PA. 1999. Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathology 9:69-92.
67. Sundqvist E, Sundstrom P, Linden M, Hedstrom AK, Aloisi F, Hillert J, Kockum I, Alfredsson L, Olsson T. 2012. Lack of replication of interaction between EBNA1 IgG and smoking in risk for multiple sclerosis. Neurology 79:1363-1368 DOI 10.1212/WNL.0b013e31826c1ab7.
68. Sundstrom P, Nystrom L, Hallmans G. 2008. Smoke exposure increases the risk for multiple sclerosis. European Journal of Neurology 15:579-583 DOI 10.1111/j.1468-1331.2008.02122.x.
69. Thorogood M, Hannaford PC. 1998. The influence of oral contraceptives on the risk of multiple sclerosis. British Journal of Obstetrics and Gynaecology 105:1296-1299 DOI 10.1111/j.1471-0528.1998.tb10008.x.
70. Turner AP, Kivlahan DR, Kazis LE, Haselkorn JK. 2007. Smoking among veterans with multiple sclerosis: prevalence correlates, quit attempts, and unmet need for services. Archives of Physical Medicine and Rehabilitation 88:1394-1399 DOI 10.1016/j.apmr.2007.08.003.
71. Villard-Mackintosh L, Vessey MP. 1993. Oral contraceptives and reproductive factors in multiple sclerosis incidence. Contraception 47:161-168 DOI 10.1016/0010-7824(93)90088-O.
72. WHO. 2013. Atlas: multiple sclerosis resources in the world. Geneva: World Health Organization.
73. Zorzon M, Zivadinov R, Nasuelli D, Dolfini P, Bosco A, Bratina A, Tommasi MA, Locatelli L, Cazzato G. 2003. Risk factors of multiple sclerosis: a case-control study. Neurological Science 24:242-247 DOI 10.1007/s10072-003-0147-6.